nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—Methylprednisolone—multiple sclerosis	0.104	0.232	CbGbCtD
Lisinopril—ABCB1—Mitoxantrone—multiple sclerosis	0.0758	0.169	CbGbCtD
Lisinopril—ABCB1—Betamethasone—multiple sclerosis	0.0676	0.151	CbGbCtD
Lisinopril—ABCB1—Prednisolone—multiple sclerosis	0.0667	0.149	CbGbCtD
Lisinopril—ABCB1—Prednisone—multiple sclerosis	0.063	0.141	CbGbCtD
Lisinopril—ABCB1—Dexamethasone—multiple sclerosis	0.0393	0.0878	CbGbCtD
Lisinopril—ABCB1—Methotrexate—multiple sclerosis	0.0316	0.0705	CbGbCtD
Lisinopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.0221	0.329	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.00561	0.0835	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.00323	0.0482	CbGpPWpGaD
Lisinopril—Fosinopril—SLC15A2—multiple sclerosis	0.00309	0.146	CrCbGaD
Lisinopril—ACE2—Peptide hormone metabolism—BCHE—multiple sclerosis	0.00299	0.0446	CbGpPWpGaD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.00297	0.0443	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.0025	0.0373	CbGpPWpGaD
Lisinopril—Spirapril—SLC15A2—multiple sclerosis	0.00249	0.118	CrCbGaD
Lisinopril—Moexipril—SLC15A2—multiple sclerosis	0.00238	0.113	CrCbGaD
Lisinopril—Quinapril—SLC15A2—multiple sclerosis	0.00222	0.105	CrCbGaD
Lisinopril—Cilazapril—SLC15A2—multiple sclerosis	0.00222	0.105	CrCbGaD
Lisinopril—Ramipril—SLC15A2—multiple sclerosis	0.00215	0.102	CrCbGaD
Lisinopril—Trandolapril—SLC15A2—multiple sclerosis	0.00215	0.102	CrCbGaD
Lisinopril—Benazepril—SLC15A2—multiple sclerosis	0.00193	0.0914	CrCbGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00175	0.0261	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—multiple sclerosis	0.00155	0.0231	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.00144	0.0215	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.00134	0.0199	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00125	0.0187	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00125	0.0187	CbGpPWpGaD
Lisinopril—Ramipril—BCHE—multiple sclerosis	0.00113	0.0534	CrCbGaD
Lisinopril—Nateglinide—SLC15A2—multiple sclerosis	0.00111	0.0527	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—SLC30A7—multiple sclerosis	0.00106	0.0158	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PABPC1—multiple sclerosis	0.000856	0.0128	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000783	0.0117	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPL5—multiple sclerosis	0.000772	0.0115	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000713	0.0106	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000691	0.0103	CbGpPWpGaD
Lisinopril—ACE—peripheral nervous system—multiple sclerosis	0.000654	0.222	CbGeAlD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000593	0.00884	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—BCHE—multiple sclerosis	0.000565	0.00842	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000542	0.00808	CbGpPWpGaD
Lisinopril—ACE—nerve—multiple sclerosis	0.00051	0.173	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000473	0.00704	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000442	0.00659	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000442	0.00659	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000414	0.00617	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00041	0.0061	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000402	0.00599	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000398	0.00592	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	0.000382	0.0057	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000379	0.00565	CbGpPWpGaD
Lisinopril—ACE2—nervous system—multiple sclerosis	0.000351	0.119	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	0.000345	0.00514	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000345	0.00513	CbGpPWpGaD
Lisinopril—ACE2—central nervous system—multiple sclerosis	0.000338	0.115	CbGeAlD
Lisinopril—Infection—Triamcinolone—multiple sclerosis	0.000303	0.000658	CcSEcCtD
Lisinopril—Sweating—Methotrexate—multiple sclerosis	0.000303	0.000658	CcSEcCtD
Lisinopril—Infection—Methylprednisolone—multiple sclerosis	0.000303	0.000657	CcSEcCtD
Lisinopril—Haematuria—Methotrexate—multiple sclerosis	0.000301	0.000654	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000301	0.00449	CbGpPWpGaD
Lisinopril—Shock—Triamcinolone—multiple sclerosis	0.0003	0.000652	CcSEcCtD
Lisinopril—Insomnia—Prednisolone—multiple sclerosis	0.0003	0.000652	CcSEcCtD
Lisinopril—Alopecia—Prednisone—multiple sclerosis	0.0003	0.000651	CcSEcCtD
Lisinopril—Shock—Methylprednisolone—multiple sclerosis	0.0003	0.00065	CcSEcCtD
Lisinopril—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000299	0.000649	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000299	0.00445	CbGpPWpGaD
Lisinopril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Epistaxis—Methotrexate—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Paraesthesia—Prednisolone—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Tachycardia—Triamcinolone—multiple sclerosis	0.000298	0.000647	CcSEcCtD
Lisinopril—Mental disorder—Prednisone—multiple sclerosis	0.000298	0.000646	CcSEcCtD
Lisinopril—Nausea—Azathioprine—multiple sclerosis	0.000297	0.000645	CcSEcCtD
Lisinopril—Tachycardia—Methylprednisolone—multiple sclerosis	0.000297	0.000645	CcSEcCtD
Lisinopril—Skin disorder—Methylprednisolone—multiple sclerosis	0.000296	0.000642	CcSEcCtD
Lisinopril—Malnutrition—Prednisone—multiple sclerosis	0.000296	0.000641	CcSEcCtD
Lisinopril—Erythema—Prednisone—multiple sclerosis	0.000296	0.000641	CcSEcCtD
Lisinopril—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000295	0.00064	CcSEcCtD
Lisinopril—Agranulocytosis—Methotrexate—multiple sclerosis	0.000295	0.00064	CcSEcCtD
Lisinopril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000295	0.000639	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—POMC—multiple sclerosis	0.000292	0.00435	CbGpPWpGaD
Lisinopril—Asthenia—Mitoxantrone—multiple sclerosis	0.00029	0.00063	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.00029	0.00432	CbGpPWpGaD
Lisinopril—Myalgia—Betamethasone—multiple sclerosis	0.000289	0.000627	CcSEcCtD
Lisinopril—Myalgia—Dexamethasone—multiple sclerosis	0.000289	0.000627	CcSEcCtD
Lisinopril—Anxiety—Dexamethasone—multiple sclerosis	0.000288	0.000625	CcSEcCtD
Lisinopril—Anxiety—Betamethasone—multiple sclerosis	0.000288	0.000625	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—CCL2—multiple sclerosis	0.000286	0.00426	CbGpPWpGaD
Lisinopril—Discomfort—Betamethasone—multiple sclerosis	0.000286	0.00062	CcSEcCtD
Lisinopril—Discomfort—Dexamethasone—multiple sclerosis	0.000286	0.00062	CcSEcCtD
Lisinopril—Hypotension—Methylprednisolone—multiple sclerosis	0.000285	0.000618	CcSEcCtD
Lisinopril—Pain—Prednisolone—multiple sclerosis	0.000284	0.000616	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—multiple sclerosis	0.000284	0.000616	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—multiple sclerosis	0.000282	0.000611	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00028	0.000608	CcSEcCtD
Lisinopril—Vision blurred—Prednisone—multiple sclerosis	0.000279	0.000604	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—multiple sclerosis	0.000278	0.000604	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000278	0.000604	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000278	0.00414	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000278	0.000602	CcSEcCtD
Lisinopril—Oedema—Dexamethasone—multiple sclerosis	0.000277	0.000601	CcSEcCtD
Lisinopril—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000277	0.000601	CcSEcCtD
Lisinopril—Oedema—Betamethasone—multiple sclerosis	0.000277	0.000601	CcSEcCtD
Lisinopril—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000277	0.000601	CcSEcCtD
Lisinopril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000277	0.000601	CcSEcCtD
Lisinopril—Insomnia—Triamcinolone—multiple sclerosis	0.000276	0.000599	CcSEcCtD
Lisinopril—Insomnia—Methylprednisolone—multiple sclerosis	0.000276	0.000598	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000275	0.0041	CbGpPWpGaD
Lisinopril—Infection—Betamethasone—multiple sclerosis	0.000275	0.000597	CcSEcCtD
Lisinopril—Infection—Dexamethasone—multiple sclerosis	0.000275	0.000597	CcSEcCtD
Lisinopril—Ill-defined disorder—Prednisone—multiple sclerosis	0.000274	0.000595	CcSEcCtD
Lisinopril—Paraesthesia—Triamcinolone—multiple sclerosis	0.000274	0.000595	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisolone—multiple sclerosis	0.000274	0.000594	CcSEcCtD
Lisinopril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000274	0.000594	CcSEcCtD
Lisinopril—Anaemia—Prednisone—multiple sclerosis	0.000273	0.000593	CcSEcCtD
Lisinopril—Shock—Dexamethasone—multiple sclerosis	0.000273	0.000591	CcSEcCtD
Lisinopril—Shock—Betamethasone—multiple sclerosis	0.000273	0.000591	CcSEcCtD
Lisinopril—Dyspnoea—Triamcinolone—multiple sclerosis	0.000272	0.000591	CcSEcCtD
Lisinopril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000271	0.000589	CcSEcCtD
Lisinopril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000271	0.000589	CcSEcCtD
Lisinopril—Tachycardia—Dexamethasone—multiple sclerosis	0.00027	0.000587	CcSEcCtD
Lisinopril—Tachycardia—Betamethasone—multiple sclerosis	0.00027	0.000587	CcSEcCtD
Lisinopril—Angioedema—Prednisone—multiple sclerosis	0.00027	0.000586	CcSEcCtD
Lisinopril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000269	0.000583	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000268	0.000582	CcSEcCtD
Lisinopril—ACE2—brain—multiple sclerosis	0.000268	0.0911	CbGeAlD
Lisinopril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000268	0.000582	CcSEcCtD
Lisinopril—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000268	0.000581	CcSEcCtD
Lisinopril—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000268	0.000581	CcSEcCtD
Lisinopril—Malaise—Prednisone—multiple sclerosis	0.000267	0.000578	CcSEcCtD
Lisinopril—Vertigo—Prednisone—multiple sclerosis	0.000266	0.000576	CcSEcCtD
Lisinopril—Syncope—Prednisone—multiple sclerosis	0.000265	0.000575	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000265	0.00395	CbGpPWpGaD
Lisinopril—Tinnitus—Methotrexate—multiple sclerosis	0.000265	0.000574	CcSEcCtD
Lisinopril—Anorexia—Betamethasone—multiple sclerosis	0.000264	0.000573	CcSEcCtD
Lisinopril—Anorexia—Dexamethasone—multiple sclerosis	0.000264	0.000573	CcSEcCtD
Lisinopril—Urticaria—Prednisolone—multiple sclerosis	0.000264	0.000572	CcSEcCtD
Lisinopril—Fatigue—Triamcinolone—multiple sclerosis	0.000263	0.000571	CcSEcCtD
Lisinopril—Fatigue—Methylprednisolone—multiple sclerosis	0.000263	0.00057	CcSEcCtD
Lisinopril—Pain—Triamcinolone—multiple sclerosis	0.000261	0.000566	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000261	0.00389	CbGpPWpGaD
Lisinopril—Loss of consciousness—Prednisone—multiple sclerosis	0.00026	0.000564	CcSEcCtD
Lisinopril—Hypotension—Betamethasone—multiple sclerosis	0.000259	0.000562	CcSEcCtD
Lisinopril—Hypotension—Dexamethasone—multiple sclerosis	0.000259	0.000562	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—multiple sclerosis	0.000258	0.000559	CcSEcCtD
Lisinopril—Vomiting—Mitoxantrone—multiple sclerosis	0.000257	0.000558	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000256	0.000555	CcSEcCtD
Lisinopril—Rash—Mitoxantrone—multiple sclerosis	0.000255	0.000554	CcSEcCtD
Lisinopril—Dermatitis—Mitoxantrone—multiple sclerosis	0.000255	0.000553	CcSEcCtD
Lisinopril—Chills—Methotrexate—multiple sclerosis	0.000255	0.000553	CcSEcCtD
Lisinopril—Headache—Mitoxantrone—multiple sclerosis	0.000254	0.00055	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	0.000253	0.00376	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000252	0.000548	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000252	0.000548	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—multiple sclerosis	0.000252	0.000546	CcSEcCtD
Lisinopril—Myalgia—Prednisone—multiple sclerosis	0.000252	0.000546	CcSEcCtD
Lisinopril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000252	0.000546	CcSEcCtD
Lisinopril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000251	0.000545	CcSEcCtD
Lisinopril—Anxiety—Prednisone—multiple sclerosis	0.000251	0.000544	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—multiple sclerosis	0.000251	0.000544	CcSEcCtD
Lisinopril—Insomnia—Dexamethasone—multiple sclerosis	0.000251	0.000544	CcSEcCtD
Lisinopril—Insomnia—Betamethasone—multiple sclerosis	0.000251	0.000544	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00025	0.000542	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000249	0.000541	CcSEcCtD
Lisinopril—Paraesthesia—Dexamethasone—multiple sclerosis	0.000249	0.00054	CcSEcCtD
Lisinopril—Paraesthesia—Betamethasone—multiple sclerosis	0.000249	0.00054	CcSEcCtD
Lisinopril—Discomfort—Prednisone—multiple sclerosis	0.000249	0.00054	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—multiple sclerosis	0.000249	0.000539	CcSEcCtD
Lisinopril—Erythema—Methotrexate—multiple sclerosis	0.000247	0.000536	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—multiple sclerosis	0.000247	0.000536	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisolone—multiple sclerosis	0.000245	0.000531	CcSEcCtD
Lisinopril—Dyspepsia—Dexamethasone—multiple sclerosis	0.000244	0.000529	CcSEcCtD
Lisinopril—Dyspepsia—Betamethasone—multiple sclerosis	0.000244	0.000529	CcSEcCtD
Lisinopril—Urticaria—Triamcinolone—multiple sclerosis	0.000243	0.000526	CcSEcCtD
Lisinopril—Urticaria—Methylprednisolone—multiple sclerosis	0.000242	0.000525	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—multiple sclerosis	0.000242	0.000525	CcSEcCtD
Lisinopril—Body temperature increased—Triamcinolone—multiple sclerosis	0.000241	0.000524	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—multiple sclerosis	0.000241	0.000523	CcSEcCtD
Lisinopril—Oedema—Prednisone—multiple sclerosis	0.000241	0.000523	CcSEcCtD
Lisinopril—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000241	0.000523	CcSEcCtD
Lisinopril—Decreased appetite—Betamethasone—multiple sclerosis	0.000241	0.000523	CcSEcCtD
Lisinopril—Decreased appetite—Dexamethasone—multiple sclerosis	0.000241	0.000523	CcSEcCtD
Lisinopril—Nausea—Mitoxantrone—multiple sclerosis	0.00024	0.000522	CcSEcCtD
Lisinopril—Infection—Prednisone—multiple sclerosis	0.00024	0.00052	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000239	0.000519	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000239	0.000519	CcSEcCtD
Lisinopril—Nateglinide—ALB—multiple sclerosis	0.000239	0.0113	CrCbGaD
Lisinopril—Back pain—Methotrexate—multiple sclerosis	0.000239	0.000519	CcSEcCtD
Lisinopril—Fatigue—Dexamethasone—multiple sclerosis	0.000239	0.000518	CcSEcCtD
Lisinopril—Fatigue—Betamethasone—multiple sclerosis	0.000239	0.000518	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000239	0.00355	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000238	0.00355	CbGpPWpGaD
Lisinopril—Shock—Prednisone—multiple sclerosis	0.000237	0.000515	CcSEcCtD
Lisinopril—Pain—Dexamethasone—multiple sclerosis	0.000237	0.000514	CcSEcCtD
Lisinopril—Pain—Betamethasone—multiple sclerosis	0.000237	0.000514	CcSEcCtD
Lisinopril—Tachycardia—Prednisone—multiple sclerosis	0.000236	0.000511	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—multiple sclerosis	0.000234	0.000508	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—multiple sclerosis	0.000233	0.000506	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—multiple sclerosis	0.000233	0.000505	CcSEcCtD
Lisinopril—Anorexia—Prednisone—multiple sclerosis	0.00023	0.000499	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00023	0.00342	CbGpPWpGaD
Lisinopril—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000229	0.000497	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—multiple sclerosis	0.000228	0.000495	CcSEcCtD
Lisinopril—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000228	0.000495	CcSEcCtD
Lisinopril—Feeling abnormal—Betamethasone—multiple sclerosis	0.000228	0.000495	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000227	0.000492	CcSEcCtD
Lisinopril—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000227	0.000492	CcSEcCtD
Lisinopril—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000225	0.000488	CcSEcCtD
Lisinopril—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000224	0.000487	CcSEcCtD
Lisinopril—Malaise—Methotrexate—multiple sclerosis	0.000223	0.000483	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—multiple sclerosis	0.000222	0.000482	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—multiple sclerosis	0.000221	0.00048	CcSEcCtD
Lisinopril—Urticaria—Dexamethasone—multiple sclerosis	0.00022	0.000478	CcSEcCtD
Lisinopril—Urticaria—Betamethasone—multiple sclerosis	0.00022	0.000478	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00022	0.000477	CcSEcCtD
Lisinopril—Dizziness—Prednisolone—multiple sclerosis	0.00022	0.000476	CcSEcCtD
Lisinopril—Asthenia—Triamcinolone—multiple sclerosis	0.000219	0.000475	CcSEcCtD
Lisinopril—Body temperature increased—Betamethasone—multiple sclerosis	0.000219	0.000475	CcSEcCtD
Lisinopril—Body temperature increased—Dexamethasone—multiple sclerosis	0.000219	0.000475	CcSEcCtD
Lisinopril—Abdominal pain—Betamethasone—multiple sclerosis	0.000219	0.000475	CcSEcCtD
Lisinopril—Abdominal pain—Dexamethasone—multiple sclerosis	0.000219	0.000475	CcSEcCtD
Lisinopril—Asthenia—Methylprednisolone—multiple sclerosis	0.000219	0.000474	CcSEcCtD
Lisinopril—Insomnia—Prednisone—multiple sclerosis	0.000218	0.000473	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—multiple sclerosis	0.000217	0.00047	CcSEcCtD
Lisinopril—Pruritus—Triamcinolone—multiple sclerosis	0.000216	0.000469	CcSEcCtD
Lisinopril—Cough—Methotrexate—multiple sclerosis	0.000216	0.000468	CcSEcCtD
Lisinopril—Pruritus—Methylprednisolone—multiple sclerosis	0.000216	0.000468	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000215	0.0032	CbGpPWpGaD
Lisinopril—Dyspepsia—Prednisone—multiple sclerosis	0.000212	0.000461	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000211	0.00314	CbGpPWpGaD
Lisinopril—Arthralgia—Methotrexate—multiple sclerosis	0.00021	0.000456	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—multiple sclerosis	0.00021	0.000456	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—multiple sclerosis	0.00021	0.000456	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—multiple sclerosis	0.00021	0.000455	CcSEcCtD
Lisinopril—Rash—Prednisolone—multiple sclerosis	0.000209	0.000454	CcSEcCtD
Lisinopril—Dermatitis—Prednisolone—multiple sclerosis	0.000209	0.000454	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000209	0.000453	CcSEcCtD
Lisinopril—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000208	0.000452	CcSEcCtD
Lisinopril—Fatigue—Prednisone—multiple sclerosis	0.000208	0.000451	CcSEcCtD
Lisinopril—Headache—Prednisolone—multiple sclerosis	0.000208	0.000451	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—multiple sclerosis	0.000208	0.000451	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000207	0.00308	CbGpPWpGaD
Lisinopril—Constipation—Prednisone—multiple sclerosis	0.000206	0.000448	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—multiple sclerosis	0.000203	0.000441	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000203	0.00302	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000203	0.00302	CbGpPWpGaD
Lisinopril—Dizziness—Triamcinolone—multiple sclerosis	0.000202	0.000438	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000202	0.000437	CcSEcCtD
Lisinopril—Dizziness—Methylprednisolone—multiple sclerosis	0.000201	0.000437	CcSEcCtD
Lisinopril—Infection—Methotrexate—multiple sclerosis	0.0002	0.000435	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisone—multiple sclerosis	0.000199	0.000431	CcSEcCtD
Lisinopril—Asthenia—Betamethasone—multiple sclerosis	0.000199	0.000431	CcSEcCtD
Lisinopril—Asthenia—Dexamethasone—multiple sclerosis	0.000199	0.000431	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000198	0.00294	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000197	0.000428	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000197	0.000428	CcSEcCtD
Lisinopril—Nausea—Prednisolone—multiple sclerosis	0.000197	0.000428	CcSEcCtD
Lisinopril—Pruritus—Betamethasone—multiple sclerosis	0.000196	0.000425	CcSEcCtD
Lisinopril—Pruritus—Dexamethasone—multiple sclerosis	0.000196	0.000425	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—multiple sclerosis	0.000196	0.000425	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000195	0.000423	CcSEcCtD
Lisinopril—Vomiting—Triamcinolone—multiple sclerosis	0.000194	0.000421	CcSEcCtD
Lisinopril—Vomiting—Methylprednisolone—multiple sclerosis	0.000194	0.00042	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000193	0.00288	CbGpPWpGaD
Lisinopril—Rash—Triamcinolone—multiple sclerosis	0.000193	0.000418	CcSEcCtD
Lisinopril—Dermatitis—Triamcinolone—multiple sclerosis	0.000192	0.000417	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—multiple sclerosis	0.000192	0.000417	CcSEcCtD
Lisinopril—Rash—Methylprednisolone—multiple sclerosis	0.000192	0.000417	CcSEcCtD
Lisinopril—Dermatitis—Methylprednisolone—multiple sclerosis	0.000192	0.000416	CcSEcCtD
Lisinopril—Urticaria—Prednisone—multiple sclerosis	0.000192	0.000416	CcSEcCtD
Lisinopril—Headache—Triamcinolone—multiple sclerosis	0.000191	0.000415	CcSEcCtD
Lisinopril—Headache—Methylprednisolone—multiple sclerosis	0.000191	0.000414	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—multiple sclerosis	0.000191	0.000414	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—multiple sclerosis	0.000191	0.000414	CcSEcCtD
Lisinopril—Diarrhoea—Betamethasone—multiple sclerosis	0.00019	0.000411	CcSEcCtD
Lisinopril—Diarrhoea—Dexamethasone—multiple sclerosis	0.00019	0.000411	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—multiple sclerosis	0.000188	0.000409	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000184	0.000399	CcSEcCtD
Lisinopril—Dizziness—Dexamethasone—multiple sclerosis	0.000183	0.000397	CcSEcCtD
Lisinopril—Dizziness—Betamethasone—multiple sclerosis	0.000183	0.000397	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—multiple sclerosis	0.000182	0.000396	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000182	0.00271	CbGpPWpGaD
Lisinopril—Nausea—Triamcinolone—multiple sclerosis	0.000181	0.000393	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—multiple sclerosis	0.000181	0.000393	CcSEcCtD
Lisinopril—Nausea—Methylprednisolone—multiple sclerosis	0.000181	0.000393	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000181	0.0027	CbGpPWpGaD
Lisinopril—Dyspnoea—Methotrexate—multiple sclerosis	0.00018	0.00039	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—multiple sclerosis	0.000179	0.000389	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000179	0.00267	CbGpPWpGaD
Lisinopril—Hypersensitivity—Prednisone—multiple sclerosis	0.000178	0.000386	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—multiple sclerosis	0.000178	0.000385	CcSEcCtD
Lisinopril—Vomiting—Betamethasone—multiple sclerosis	0.000176	0.000382	CcSEcCtD
Lisinopril—Vomiting—Dexamethasone—multiple sclerosis	0.000176	0.000382	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—multiple sclerosis	0.000175	0.00038	CcSEcCtD
Lisinopril—Rash—Betamethasone—multiple sclerosis	0.000175	0.000379	CcSEcCtD
Lisinopril—Rash—Dexamethasone—multiple sclerosis	0.000175	0.000379	CcSEcCtD
Lisinopril—Dermatitis—Betamethasone—multiple sclerosis	0.000175	0.000379	CcSEcCtD
Lisinopril—Dermatitis—Dexamethasone—multiple sclerosis	0.000175	0.000379	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000174	0.000378	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—multiple sclerosis	0.000174	0.000377	CcSEcCtD
Lisinopril—Headache—Dexamethasone—multiple sclerosis	0.000174	0.000377	CcSEcCtD
Lisinopril—Headache—Betamethasone—multiple sclerosis	0.000174	0.000377	CcSEcCtD
Lisinopril—Asthenia—Prednisone—multiple sclerosis	0.000173	0.000376	CcSEcCtD
Lisinopril—Pain—Methotrexate—multiple sclerosis	0.000172	0.000374	CcSEcCtD
Lisinopril—Pruritus—Prednisone—multiple sclerosis	0.000171	0.00037	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—multiple sclerosis	0.000166	0.000361	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—multiple sclerosis	0.000165	0.000358	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000165	0.000358	CcSEcCtD
Lisinopril—Nausea—Betamethasone—multiple sclerosis	0.000165	0.000357	CcSEcCtD
Lisinopril—Nausea—Dexamethasone—multiple sclerosis	0.000165	0.000357	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000163	0.00244	CbGpPWpGaD
Lisinopril—Urticaria—Methotrexate—multiple sclerosis	0.00016	0.000348	CcSEcCtD
Lisinopril—Dizziness—Prednisone—multiple sclerosis	0.00016	0.000346	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—multiple sclerosis	0.000159	0.000346	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—multiple sclerosis	0.000159	0.000346	CcSEcCtD
Lisinopril—Vomiting—Prednisone—multiple sclerosis	0.000153	0.000333	CcSEcCtD
Lisinopril—Rash—Prednisone—multiple sclerosis	0.000152	0.00033	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—multiple sclerosis	0.000152	0.00033	CcSEcCtD
Lisinopril—Headache—Prednisone—multiple sclerosis	0.000151	0.000328	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000151	0.00225	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000149	0.00222	CbGpPWpGaD
Lisinopril—Hypersensitivity—Methotrexate—multiple sclerosis	0.000149	0.000322	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—multiple sclerosis	0.000145	0.000314	CcSEcCtD
Lisinopril—Nausea—Prednisone—multiple sclerosis	0.000143	0.000311	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—multiple sclerosis	0.000143	0.00031	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—multiple sclerosis	0.000138	0.000299	CcSEcCtD
Lisinopril—ACE—spinal cord—multiple sclerosis	0.000136	0.0463	CbGeAlD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000134	0.002	CbGpPWpGaD
Lisinopril—Dizziness—Methotrexate—multiple sclerosis	0.000133	0.000289	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000131	0.00195	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—POMC—multiple sclerosis	0.00013	0.00194	CbGpPWpGaD
Lisinopril—Vomiting—Methotrexate—multiple sclerosis	0.000128	0.000278	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	0.000128	0.0019	CbGpPWpGaD
Lisinopril—Rash—Methotrexate—multiple sclerosis	0.000127	0.000276	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—multiple sclerosis	0.000127	0.000276	CcSEcCtD
Lisinopril—Headache—Methotrexate—multiple sclerosis	0.000126	0.000274	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000122	0.00181	CbGpPWpGaD
Lisinopril—Nausea—Methotrexate—multiple sclerosis	0.00012	0.00026	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	0.000119	0.00178	CbGpPWpGaD
Lisinopril—ACE—nervous system—multiple sclerosis	0.000115	0.039	CbGeAlD
Lisinopril—ACE—central nervous system—multiple sclerosis	0.00011	0.0375	CbGeAlD
Lisinopril—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	0.000106	0.00159	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL2—multiple sclerosis	0.000106	0.00158	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000105	0.00156	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000102	0.00152	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	8.98e-05	0.00134	CbGpPWpGaD
Lisinopril—ACE—brain—multiple sclerosis	8.77e-05	0.0298	CbGeAlD
Lisinopril—ABCB1—Metabolism—SRM—multiple sclerosis	8.31e-05	0.00124	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.28e-05	0.00123	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.06e-05	0.0012	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—multiple sclerosis	7.73e-05	0.00115	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.58e-05	0.00113	CbGpPWpGaD
Lisinopril—ABCB1—retina—multiple sclerosis	7.44e-05	0.0253	CbGeAlD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.12e-05	0.00106	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP24A1—multiple sclerosis	5.85e-05	0.000872	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP27B1—multiple sclerosis	5.85e-05	0.000872	CbGpPWpGaD
Lisinopril—ABCB1—medulla oblongata—multiple sclerosis	5.38e-05	0.0183	CbGeAlD
Lisinopril—ABCB1—Metabolism—GPC5—multiple sclerosis	5.35e-05	0.000798	CbGpPWpGaD
Lisinopril—ABCB1—midbrain—multiple sclerosis	4.91e-05	0.0167	CbGeAlD
Lisinopril—ABCB1—spinal cord—multiple sclerosis	4.79e-05	0.0163	CbGeAlD
Lisinopril—ABCB1—Metabolism—RRM1—multiple sclerosis	4.44e-05	0.000661	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.09e-05	0.00061	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.08e-05	0.000608	CbGpPWpGaD
Lisinopril—ABCB1—nervous system—multiple sclerosis	4.04e-05	0.0137	CbGeAlD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4e-05	0.000597	CbGpPWpGaD
Lisinopril—ABCB1—central nervous system—multiple sclerosis	3.89e-05	0.0132	CbGeAlD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.81e-05	0.000568	CbGpPWpGaD
Lisinopril—ABCB1—cerebellum—multiple sclerosis	3.8e-05	0.0129	CbGeAlD
Lisinopril—ABCB1—brain—multiple sclerosis	3.09e-05	0.0105	CbGeAlD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.56e-05	0.000382	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BCHE—multiple sclerosis	2.55e-05	0.00038	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—multiple sclerosis	1.53e-05	0.000228	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—multiple sclerosis	1.32e-05	0.000196	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—multiple sclerosis	1.2e-05	0.000179	CbGpPWpGaD
